OBJECTIVES: The validity of 3 Tesla motor functional magnetic resonance imaging (fMRI) in patients with gliomas involving the primary motor cortex was investigated by intraoperative navigated motor cortex stimulation (MCS). METHODS: Twenty two patients (10 males, 12 females, mean age 39 years, range 10-65 years) underwent preoperative fMRI studies, performing motor tasks including hand, foot, and mouth movements. A recently developed high field clinical fMRI technique was used to generate pre-surgical maps of functional high risk areas defining a motor focus. Motor foci were tested for validity by intraoperative motor cortex stimulation (MCS) employing image fusion and neuronavigation. Clinical outcome was assessed using the Modified Rankin Scale. RESULTS: FMRI motor foci were successfully detected in all patients preoperatively. In 17 of 22 patients (77.3%), a successful stimulation of the primary motor cortex was possible. All 17 correlated patients showed 100% agreement on MCS and fMRI motor focus within 10 mm. Technical problems during stimulation occurred in three patients (13.6%), no motor response was elicited in two (9.1%), and MCS induced seizures occurred in three (13.6%). Combined fMRI and MCS mapping results allowed large resections in 20 patients (91%) (gross total in nine (41%), subtotal in 11 (50%)) and biopsy in two patients (9%). Pathology revealed seven low grade and 15 high grade gliomas. Mild to moderate transient neurological deterioration occurred in six patients, and a severe hemiparesis in one. All patients recovered within 3 months (31.8% transient, 0% permanent morbidity). CONCLUSIONS: The validation of clinically optimised high magnetic field motor fMRI confirms high reliability as a preoperative and intraoperative adjunct in glioma patients selected for surgery within or adjacent to the motor cortex.
OBJECTIVES: The validity of 3 Tesla motor functional magnetic resonance imaging (fMRI) in patients with gliomas involving the primary motor cortex was investigated by intraoperative navigated motor cortex stimulation (MCS). METHODS: Twenty two patients (10 males, 12 females, mean age 39 years, range 10-65 years) underwent preoperative fMRI studies, performing motor tasks including hand, foot, and mouth movements. A recently developed high field clinical fMRI technique was used to generate pre-surgical maps of functional high risk areas defining a motor focus. Motor foci were tested for validity by intraoperative motor cortex stimulation (MCS) employing image fusion and neuronavigation. Clinical outcome was assessed using the Modified Rankin Scale. RESULTS: FMRI motor foci were successfully detected in all patients preoperatively. In 17 of 22 patients (77.3%), a successful stimulation of the primary motor cortex was possible. All 17 correlated patients showed 100% agreement on MCS and fMRI motor focus within 10 mm. Technical problems during stimulation occurred in three patients (13.6%), no motor response was elicited in two (9.1%), and MCS induced seizures occurred in three (13.6%). Combined fMRI and MCS mapping results allowed large resections in 20 patients (91%) (gross total in nine (41%), subtotal in 11 (50%)) and biopsy in two patients (9%). Pathology revealed seven low grade and 15 high grade gliomas. Mild to moderate transient neurological deterioration occurred in six patients, and a severe hemiparesis in one. All patients recovered within 3 months (31.8% transient, 0% permanent morbidity). CONCLUSIONS: The validation of clinically optimised high magnetic field motor fMRI confirms high reliability as a preoperative and intraoperative adjunct in gliomapatients selected for surgery within or adjacent to the motor cortex.
Authors: S Lehéricy; H Duffau; P Cornu; L Capelle; B Pidoux; A Carpentier; S Auliac; S Clemenceau; J P Sichez; A Bitar; C A Valery; R Van Effenterre; T Faillot; A Srour; D Fohanno; J Philippon; D Le Bihan; C Marsault Journal: J Neurosurg Date: 2000-04 Impact factor: 5.115
Authors: R Beisteiner; R Lanzenberger; K Novak; V Edward; C Windischberger; M Erdler; R Cunnington; A Gartus; B Streibl; E Moser; T Czech; L Deecke Journal: Neurosci Lett Date: 2000-08-18 Impact factor: 3.046
Authors: T Krings; M H Reinges; S Erberich; S Kemeny; V Rohde; U Spetzger; M Korinth; K Willmes; J M Gilsbach; A Thron Journal: J Neurol Neurosurg Psychiatry Date: 2001-06 Impact factor: 10.154
Authors: R Beisteiner; C Windischberger; R Lanzenberger; V Edward; R Cunnington; M Erdler; A Gartus; B Streibl; E Moser; L Deecke Journal: Neuroimage Date: 2001-06 Impact factor: 6.556
Authors: V Edward; C Windischberger; R Cunnington; M Erdler; R Lanzenberger; D Mayer; W Endl; R Beisteiner Journal: Hum Brain Mapp Date: 2000-11 Impact factor: 5.038
Authors: Alexander Geissler; Rupert Lanzenberger; Markus Barth; Amir Reza Tahamtan; Denny Milakara; Andreas Gartus; Roland Beisteiner Journal: Neuroimage Date: 2004-12-10 Impact factor: 6.556
Authors: Hagen Schiffbauer; Mitchel S Berger; Paul Ferrari; Dirk Freudenstein; Howard A Rowley; Timothy P L Roberts Journal: J Neurosurg Date: 2002-12 Impact factor: 5.115
Authors: Neculai Archip; Olivier Clatz; Stephen Whalen; Dan Kacher; Andriy Fedorov; Andriy Kot; Nikos Chrisochoides; Ferenc Jolesz; Alexandra Golby; Peter M Black; Simon K Warfield Journal: Neuroimage Date: 2006-12-23 Impact factor: 6.556
Authors: Thomas A Gallagher; Veena A Nair; Michael F Regner; Brittany M Young; Andrew Radtke; Joshua Pankratz; Ryan L Holdsworth; Dovile Baniulis; Nicole K Kornder; Jed Voss; Benjamin P Austin; Chad Moritz; Elizabeth M Meyerand; Vivek Prabhakaran Journal: Neurosurg Focus Date: 2013-04 Impact factor: 4.047